Andy Page, the former president of 23andMe, has joined Livongo, a chronic disease-focused startup, CNBC reports.
Livongo in particular aims to help patients with diabetes manage their condition. According to CNBC, the company provides patients with blood glucose monitors and testing strips. When they have a result that's outside the normal range, a Livongo coach steps in to offer to feedback and if that doesn't work, a specialist is then brought in, it adds. "The idea is to reduce strain on the healthcare system," Page tells CNBC.
Page left 23andMe last November. While there, he oversaw the firm's product and engineering, marketing, laboratory operations, and legal and regulatory affairs, among other areas.
CNBC adds that Glen Tullman, the former CEO of Allscripts, a health information technology company, started Livongo in 2014.